Currently most clinical trial are designed to be randomized, double-blind, and placebo-controlled. This means that each study subject is randomly assigned to receive one of the treatments, which might be the placebo. Neither the subjects nor scientists involved in the study know which study treatment is being administered to any given subject; and, in particular, none of those involved in the study know which subjects are being administered a placebo.
Most clinical trials require large numbers of participants and sometimes it is necessary to organize multicenter clinical trials. Often the centres taking part in such trials are in different countries (in which case they are termed international clinical trials).
Search Encyclopedia
|
Featured Article
|